Price Alert

CONMED Corporation (CNMD)

NYSE: CNMD · Real-Time Price · USD

52.87

0.23 (0.44%)

At close: Aug 15, 2025, 12:18 PM

CONMED Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	1.33B	1.32B	1.31B	1.29B	1.27B	1.26B	1.24B	1.17B	1.14B	1.1B	1.05B	1.07B	1.04B	1.02B	1.01B	989.49M	978.5M	881.13M
Cost of Revenue	582.84M	586.4M	592.55M	587.67M	586.48M	575.85M	566.34M	542.63M	529.59M	508.04M	474.23M	473.34M	456.38M	444.71M	442.6M	441.8M	439.42M	411.54M
Gross Profit	745.4M	730.24M	714.46M	698.46M	687.52M	685.06M	678.4M	625.93M	609.49M	590.58M	571.25M	595.24M	585.93M	575.58M	568.03M	547.69M	539.09M	469.59M
Operating Income	172.32M	171.38M	197.71M	188.18M	152.77M	142.98M	95.45M	51.39M	27.71M	24.75M	35.6M	73.91M	94M	95.25M	109.72M	97.2M	99.87M	52.92M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	137.69M	145.28M	163.03M	160.07M	123.9M	103.8M	80.83M	29.61M	25.04M	-85.86M	-70.86M	-30.68M	-28.95M	80.82M	73.1M	56.95M	56.87M	7.84M
Net Income	110.2M	118.75M	132.42M	131.74M	98.59M	82.35M	64.46M	57.97M	88.28M	-93.74M	-80.58M	-82.72M	-113.92M	67.66M	62.54M	62.24M	54.14M	13.45M
Selling & General & Admin	513.27M	499.09M	460.34M	455M	480.57M	488.42M	512.41M	505.81M	495.12M	481.25M	454.04M	440.58M	430.72M	419.29M	414.75M	406.57M	396.22M	376.29M
Research & Development	53.82M	53.78M	54.43M	55.28M	54.18M	53.66M	52.6M	50.8M	51.1M	49.02M	47.15M	46.29M	44.38M	44.21M	43.56M	43.92M	43M	40.38M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1.13M	-1.13M	-1.13M	-1.22M	-178K	-267K
Operating Expenses	571.09M	556.87M	514.77M	510.28M	534.75M	542.08M	565.01M	556.61M	546.22M	530.26M	501.19M	486.87M	475.1M	463.5M	458.32M	450.49M	439.21M	416.67M
Interest Expense	34.22M	35.99M	37.3M	37.94M	38.71M	39.12M	39.78M	39.71M	38.23M	34.16M	28.91M	27.03M	26.64M	30.13M	35.48M	39.03M	42.83M	44.81M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.23M	3.23M	3.23M
Cost & Expenses	1.15B	1.14B	1.11B	1.1B	1.12B	1.12B	1.13B	1.1B	1.08B	1.04B	975.42M	960.21M	931.49M	908.21M	900.92M	892.29M	878.63M	828.21M
Income Tax Expense	27.49M	26.53M	30.61M	28.33M	25.3M	21.45M	16.37M	-28.36M	-63.25M	7.88M	9.72M	52.05M	84.97M	13.16M	10.56M	-5.28M	2.73M	-5.61M
Shares Outstanding (Basic)	30.95M	30.97M	30.85M	30.86M	30.81M	30.78M	30.76M	30.74M	30.66M	30.51M	30.48M	30.47M	29.77M	35.16M	29.35M	29.18M	29.13M	28.97M
Shares Outstanding (Diluted)	31.05M	31.15M	31.11M	31.11M	31.11M	31.27M	31.5M	31.69M	31.8M	31.2M	30.93M	31.1M	29.77M	35.16M	32.77M	32.14M	32.46M	31.38M
EPS (Basic)	3.56	3.84	4.29	4.28	3.21	2.69	2.11	1.90	2.89	-3.21	-2.84	-2.88	-3.88	2.23	2.14	2.15	1.88	0.46
EPS (Diluted)	3.53	3.80	4.24	4.21	3.14	2.61	2.04	1.85	2.83	-3.25	-2.88	-2.99	-4	2.06	1.94	2.00	1.76	0.39
EBITDA	226.56M	235.5M	256.23M	246.69M	193.31M	173.62M	131.39M	87.06M	81.01M	-21.71M	-11.96M	26.09M	39.5M	140.51M	156.42M	144.37M	156.38M	122.43M
EBIT	171.91M	181.27M	200.33M	198.01M	162.61M	142.92M	120.6M	69.32M	63.27M	-51.7M	-41.96M	-3.65M	-2.31M	110.95M	108.59M	95.98M	99.69M	52.65M
Depreciation & Amortization	54.23M	67M	61.39M	61.39M	56.04M	56.24M	56.45M	56.18M	56.2M	55.49M	54.66M	54.41M	53.84M	53.77M	60.02M	60.57M	66.46M	72.48M